Lincoln Pharmaceuticals Limited: board meetings

48 records, the earliest from 11 Feb 2016. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.

48 shown.

Sign in to see more, or upgrade your plan to see the full history. Sign in

DatePurposeNotes
13 Aug 2026Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2026
28 May 2026Financial Results/DividendTo consider and approve the Audited (Standalone & Consolidated) financial results for the Quarter and Year ended March 31, 2026 and recommendation of dividend on equity shares of the Company, if any.
12 Feb 2026Financial ResultsIntimation of board meeting of the Company to consider and approve the unaudited (Standalone and Consolidated) financial results for the period ended December 31, 2025.
13 Nov 2025Financial ResultsTo consider and approve the financial results for the period ended September 30, 2025
7 Aug 2025Financial ResultsIntimation of Board Meeting to consider and approve the unaudited financial results for the period ended Jun 30, 2025.
22 May 2025Financial Results/DividendTo consider and approve the Audited (Standalone & Consolidated) financial results for the Quarter and Year ended March 31, 2025 and recommendation of dividend on equity shares of the Company, if any.
13 Feb 2025Financial ResultsIntimation of Board Meeting to consider and approve the unaudited (Standalone & Consolidated) financial results for the period ended December 31, 2024.
14 Nov 2024Financial ResultsIntimation of Board Meeting to consider and approve the unaudited (Standalone & Consolidated) financial results for the period ended September 30, 2024.
8 Aug 2024Financial ResultsIntimation of Board Meeting to consider and approve the unaudited (standalone & consolidated) financial results for the period ended Jun 30, 2024 along with any other business, if any.
16 May 2024Financial Results/DividendTo consider and approve the Audited financial results (Standalone & Consolidated)of the Company for the Quarter and Year ended March 31, 2024 and recommendation of dividend if any.

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.